KRAS, NRAS,BRAF mutation testing Doctors Abroad — Page 3

Dr. Shruti Kate heads the oncology department at HCG Manavata Cancer Centre. She previously served as a consultant at the prestigious Tata Memorial Hospital.

• Specializes in solid tumors and pediatric cancers requiring KRAS, NRAS, and BRAF mutation testing
• Presented lung cancer research at the 2018 World Conference on Lung Cancer in Toronto
• Won a travel award from the International Association for the Study of Lung Cancer
• Member of the American Society of Clinical Oncology and the European Society for Medical Oncology
• Expert in using immunotherapy and metronomic therapy for advanced cancer stages

Dr. Chaitainya Borde has handled more than 30,000 PET scans at HCG Manavata Cancer Centre. This experience supports precise KRAS, NRAS, and BRAF mutation testing for cancer patients.

• Specializes in nuclear medicine – provides detailed imaging for accurate diagnosis
• Expert in all PET-CT scans for tracking cancer growth
• Published medical papers on advanced imaging and therapy
• Experienced in radioiodine and Lu-177 RN therapies for cancer
• Treated 1,000+ thyroid cancer patients using specialized nuclear services

Dr. Antonio Cubillo Gracián pioneered the first liquid biopsy program in Spain. He uses genetic data to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.

• Heads the Medical Oncology Service at Hospital Universitario HM Sanchinarro
• Directs postgraduate research at HM CIOCC, a leading Spanish cancer center
• Uses molecular markers like EGFR and ALK to design personalized cancer treatment plans
• Leads clinical trials for new cancer therapies through the Start Madrid program
• Member of the teacher faculty at USP CEU medical school